Challenges to Biosimilar Substitution-Reply
JAMA
.
2017 Sep 26;318(12):1186-1187.
doi: 10.1001/jama.2017.11937.
Authors
Aaron Hakim
1
,
Joseph S Ross
1
Affiliation
1
Yale University School of Medicine, New Haven, Connecticut.
PMID:
28973611
DOI:
10.1001/jama.2017.11937
No abstract available
Publication types
Letter
Comment
MeSH terms
Biosimilar Pharmaceuticals*
Drug Approval*
Humans
Substances
Biosimilar Pharmaceuticals